Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.8%

1 terminated/withdrawn out of 36 trials

Success Rate

93.3%

+6.8% vs industry average

Late-Stage Pipeline

28%

10 trials in Phase 3/4

Results Transparency

7%

1 of 14 completed trials have results

Key Signals

8 recruiting1 with results

Enrollment Performance

Analytics

N/A
18(56.3%)
Phase 4
6(18.8%)
Phase 3
4(12.5%)
Phase 2
3(9.4%)
Phase 1
1(3.1%)
32Total
N/A(18)
Phase 4(6)
Phase 3(4)
Phase 2(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (36)

Showing 20 of 36 trials
NCT07529262Phase 3Not Yet Recruiting

Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial

Role: lead

NCT07060404Phase 2Not Yet Recruiting

Postpartum 8-aminoquinoline Breast Milk Study

Role: lead

NCT07052162Phase 4Recruiting

Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children

Role: lead

NCT07468526Phase 3Not Yet Recruiting

An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria

Role: collaborator

NCT07468513Phase 4Recruiting

Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

Role: collaborator

NCT07403643Phase 4Not Yet Recruiting

Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria

Role: lead

NCT03829631Not ApplicableRecruiting

Lumbar Brace Deployment in the Emergency Department for Benign Low Back Pain

Role: collaborator

NCT06593847Not ApplicableCompleted

Multisite Virtual Reality Intervention for Speech Anxiety

Role: collaborator

NCT03138005Not ApplicableTerminated

Reduction of Oxygen After Cardiac Arrest

Role: collaborator

NCT06148792Phase 3Recruiting

A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria

Role: collaborator

NCT05426434Phase 3Active Not Recruiting

Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy

Role: collaborator

NCT06985641Not ApplicableNot Yet Recruiting

Khanya Ekhaya: A Home-Based Intervention

Role: collaborator

NCT05225740Not ApplicableCompleted

Exposure Therapy Consortium (ETC) for Anxiety Sensitivity

Role: collaborator

NCT04536870Not ApplicableActive Not Recruiting

Statins in Reducing Events in the Elderly (STAREE) Heart Sub-study

Role: collaborator

NCT05761067Not ApplicableRecruiting

STICH-3.0 International Trial Consortium

Role: collaborator

NCT06545435Recruiting

Predicting Appendicular Lean and Fat Mass With Bioelectrical Impedance Analysis Among Adult Patients With Obesity.

Role: collaborator

NCT05972785Active Not Recruiting

Long-term Use of CCB and Breast Cancer Risk

Role: lead

NCT05348694Phase 4Unknown

OsteoPreP: Food Supplements for Postmenopausal Bone Health

Role: collaborator

NCT06456931Not ApplicableRecruiting

A Pilot Study Comparing the Efficacy of Traditional Buddhist Mindfulness Training Versus Secular Mindfulness-based Cognitive Therapy for Patients Having Residual Depressive Symptoms

Role: collaborator

NCT04399772Not ApplicableCompleted

COgNitive FuncTional Therapy+ for Chronic Low Back paIn

Role: collaborator